Also trades as: BHC.TO (TSX) · $vol 4M
BHC NYSE
Bausch Health Companies Inc.
1W: -1.7%
1M: +9.4%
3M: +34.8%
YTD: -12.5%
1Y: +1.8%
3Y: -13.8%
5Y: -77.8%
$6.31
-0.04 (-0.71%)
Pre-Market: $6.40 (+0.09, +1.51%)
Weekly Expected Move ±4.4%
$6
$6
$6
$7
$7
Credit Risk of going bust: higher than 87% of companies Debt: 89.8% of company value Bonds: $300.9M held by 287 funds, 1254 bp over Treasuries → details ▾
If the stock fell to about $1.86 (down 71%), Bausch Health Companies Inc. would be worth roughly what it owes.
Total debt $20.78B against a stock market value of $2.36B.
Distance to default 1.94 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $10.80B (short-term plus half of long-term), stock volatility 54.1%; Altman Z'' -0.73. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Total debt $20.78B against a stock market value of $2.36B.
Distance to default 1.94 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $10.80B (short-term plus half of long-term), stock volatility 54.1%; Altman Z'' -0.73. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
#25
of 304
Drug Manufacturers - Specialty & Generic
Technical Signal Map
27 Bullish
4 Neutral
25 Bearish
BHC
$2.4B
Bausch Health Companies Inc.
BULLISH
+66
TKPHF
$66B
Takeda Pharmaceutical Company Limited
BULLISH
+100
ALKS
$7.3B
Alkermes plc
BULLISH
+100
AMRX
$6.5B
Amneal Pharmaceuticals, Inc.
BULLISH
+100
SDZNY
$42B
Sandoz Group AG
BULLISH
+91
PRGO
$2.2B
Perrigo Company plc
BULLISH
+91
RDY
$11B
Dr. Reddy's Laboratories Limited
BULLISH
+84
HKMPY
$4.6B
Hikma Pharmaceuticals PLC
BULLISH
+82
ZTS
$33B
Zoetis Inc.
BULLISH
+78
VTRS
$21B
Viatris Inc.
BULLISH
+75
ESAIY
$9.2B
Eisai Co., Ltd.
BULLISH
+66
HLUBF
$7.3B
H. Lundbeck A/S
BULLISH
+58
PCRX
$1.4B
Pacira BioSciences, Inc.
BULLISH
+58
KHTRF
$810M
Knight Therapeutics Inc.
BULLISH
+58
HLN
$45B
Haleon plc
BULLISH
+53
LVZPF
$6.1B
Livzon Pharmaceutical Group Inc.
BULLISH
+53
CRON
$1.2B
Cronos Group Inc.
BULLISH
+50
TEVA
$46B
Teva Pharmaceutical Industries Limited
BULLISH
+49
PAHC
$1.6B
Phibro Animal Health Corporation
BULLISH
+42
SGIOY
$16B
Shionogi & Co., Ltd.
BULLISH
+34
APNHY
$4.2B
Aspen Pharmacare Holdings Limited
BULLISH
+33
TSMRF
$1.7B
Tsumura & Co.
LEAN BULL
+24
SWGHF
$1.3B
Sawai Group Holdings Co., Ltd.
LEAN BULL
+24
TWAPF
$1.3B
Towa Pharmaceutical Co., Ltd.
LEAN BULL
+24
KKPCF
$980M
Kaken Pharmaceutical Co., Ltd.
LEAN BULL
+24
IPSEY
$58B
Ipsen S.A.
LEAN BULL
+18
MKGAF
$70B
Merck KGaA
LEAN BULL
+16
NPNKF
$1.6B
Nippon Shinyaku Co., Ltd.
NEUTRAL
+8
DNPUF
$6.4B
Sumitomo Pharma Co., Ltd.
NEUTRAL
-3
SGFEF
$3.9B
Siegfried Holding AG
NEUTRAL
-3
AMPH
$1.1B
Amphastar Pharmaceuticals, Inc.
NEUTRAL
-9
LNTH
$6.5B
Lantheus Holdings, Inc.
LEAN BEAR
-16
ALVOW
$3.9B
Alvotech
BEARISH
-32
HCM
$2.6B
HUTCHMED (China) Limited
BEARISH
-34
BIOGY
$1.3B
BioGaia AB (publ)
BEARISH
-38
RGC
$3.8B
Regencell Bioscience Holdings Limited
BEARISH
-40
TRLV
$1.8B
Trulieve Cannabis Corp.
BEARISH
-40
LYPHF
$1.1B
Luye Pharma Group Ltd.
BEARISH
-40
HROW
$1.1B
Harrow Health, Inc.
BEARISH
-40
INDV
$4.3B
Indivior Pharmaceuticals Inc
BEARISH
-49
ANIP
$1.7B
ANI Pharmaceuticals, Inc.
BEARISH
-49
HYPMY
$3.8B
Hypera S.A.
BEARISH
-53
SUPN
$2.4B
Supernus Pharmaceuticals, Inc.
BEARISH
-58
KSPHF
$1.0B
Kissei Pharmaceutical Co., Ltd.
BEARISH
-59
ELAN
$11B
Elanco Animal Health Incorporated
BEARISH
-65
ETON
$1.4B
Eton Pharmaceuticals, Inc.
BEARISH
-69
DMPHF
$2.4B
Dermapharm Holding SE
BEARISH
-75
CURLF
$1.8B
Curaleaf Holdings, Inc.
BEARISH
-78
CHSYF
$2.7B
China Medical System Holdings Limited
BEARISH
-87
ARSUF
$2.0B
Fagron N.V.
BEARISH
-87
LABFF
$3.4B
Laboratorios Farmaceuticos Rovi, S.A.
BEARISH
-91
GTBIF
$1.4B
Green Thumb Industries Inc.
BEARISH
-91
SHPHF
$1.1B
Sihuan Pharmaceutical Holdings Group Ltd.
BEARISH
-91
CHIZF
$820M
China Traditional Chinese Medicine Holdings Co. Limited
BEARISH
-91
SFOSF
$5.8B
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
BEARISH
-100
ULIHF
$1.9B
The United Laboratories International Holdings Limited
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies Inc. | $2.4B | -2.1 | 86.8 | 12.2 | 9.0 | 10.5 | 5 | BULLISH | 1.8 |
| TKPHF Takeda Pharmaceutical Company Limited | $66B | 55.2 | 2.5 | 2.8 | 9.3 | 3.3 | 6 | BULLISH | 41.6 |
| ALKS Alkermes plc | $7.3B | 110.0 | 3.9 | 2.9 | 0.1 | 10.8 | 4 | BULLISH | 48.7 |
| AMRX Amneal Pharmaceuticals, Inc. | $6.5B | 43.1 | -395.8 | 16.0 | 7.2 | 9.3 | 8 | BULLISH | 103.2 |
| SDZNY Sandoz Group AG | $42B | 64.7 | 7.2 | 10.1 | 1.9 | 29.1 | 6 | BULLISH | 59.1 |
| PRGO Perrigo Company plc | $2.2B | -1.3 | -49.6 | 3.1 | 7.3 | -4.2 | 4 | BULLISH | -23.7 |
| RDY Dr. Reddy's Laboratories Limited | $11B | 39.7 | 7.5 | 6.0 | 10.7 | -3.1 | 4 | BULLISH | -5.7 |
| HKMPY Hikma Pharmaceuticals PLC | $4.6B | 12.6 | 15.3 | 12.1 | 12.9 | 6.1 | 7 | BULLISH | -5.2 |
| ZTS Zoetis Inc. | $33B | 12.9 | 64.4 | 26.3 | 28.0 | 1.4 | 6 | BULLISH | -46.2 |
| VTRS Viatris Inc. | $21B | -52.0 | -2.8 | -0.3 | -3.2 | 4.4 | 7 | BULLISH | 83.0 |
| ESAIY Eisai Co., Ltd. | $9.2B | 33.8 | 3.8 | 3.3 | 7.8 | 248.0 | 6 | BULLISH | 9.7 |
| HLUBF H. Lundbeck A/S | $7.3B | 13.5 | 15.2 | 12.6 | 17.6 | 10.1 | 7 | BULLISH | 22.5 |
| PCRX Pacira BioSciences, Inc. | $1.4B | 103.4 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | BULLISH | 67.4 |
| KHTRF Knight Therapeutics Inc. | $810M | 76.7 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 98.5 |
| HLN Haleon plc | $45B | 20.5 | 10.1 | 8.4 | 13.6 | 1.3 | 8 | BULLISH | 8.9 |
| LVZPF Livzon Pharmaceutical Group Inc. | $6.1B | 15.9 | 11.5 | 16.4 | 15.3 | -14.4 | 4 | BULLISH | 0.0 |
| CRON Cronos Group Inc. | $1.2B | 18.1 | 6.5 | 5.4 | 60.5 | 72.9 | 7 | BULLISH | 34.1 |
| TEVA Teva Pharmaceutical Industries Limited | $46B | 64.1 | 9.7 | 9.3 | -13.9 | 4.1 | 7 | BULLISH | 113.2 |
| PAHC Phibro Animal Health Corporation | $1.6B | 15.6 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | BULLISH | -9.1 |
| SGIOY Shionogi & Co., Ltd. | $16B | 9.7 | 13.6 | 9.9 | 50.6 | 10.3 | 5 | BULLISH | 20.6 |
| APNHY Aspen Pharmacare Holdings Limited | $4.2B | 26.8 | 3.2 | 5.3 | 6.6 | -20.1 | 7 | BULLISH | 69.4 |
| TSMRF Tsumura & Co. | $1.7B | 9.1 | 9.9 | 6.6 | 13.0 | 10.7 | 4 | LEAN BULL | 0.0 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 22.7 | 4.3 | 4.6 | 4.7 | 11.4 | 4 | LEAN BULL | 0.0 |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 20.8 | 4.7 | 3.2 | 7.7 | 7.1 | 7 | LEAN BULL | 54.4 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 13.9 | 6.9 | 7.9 | 28.0 | -6.6 | 4 | LEAN BULL | 8.3 |
| IPSEY Ipsen S.A. | $58B | 24.7 | 11.5 | 16.3 | 18.2 | 8.0 | 6 | LEAN BULL | 22.7 |
| MKGAF Merck KGaA | $70B | 26.8 | 8.1 | 8.1 | 9.0 | -0.4 | 7 | LEAN BULL | 19.4 |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.6 | 12.5 | 20.6 | 12.8 | 4 | NEUTRAL | -1.1 |
| DNPUF Sumitomo Pharma Co., Ltd. | $6.4B | 6.9 | 39.1 | 10.3 | 13.1 | 14.5 | 6 | NEUTRAL | 5.6 |
| SGFEF Siegfried Holding AG | $3.9B | 18.4 | 17.0 | 9.4 | 10.8 | 3.4 | 4 | NEUTRAL | -15.8 |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 14.7 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | NEUTRAL | 4.3 |
| LNTH Lantheus Holdings, Inc. | $6.5B | 23.8 | 22.2 | 17.1 | 19.3 | 2.3 | 5 | LEAN BEAR | 78.7 |
| ALVOW Alvotech | $3.9B | -8.1 | 98.5 | 3.3 | -63.2 | -12.2 | 0 | BEARISH | -85.2 |
| HCM HUTCHMED (China) Limited | $2.6B | 145.4 | 46.6 | 11.0 | 5.7 | -11.8 | 6 | BEARISH | -6.5 |
| BIOGY BioGaia AB (publ) | $1.3B | 31.7 | 31.8 | 52.6 | 27.5 | 13.1 | 5 | BEARISH | 19.9 |
| RGC Regencell Bioscience Holdings Limited | $3.8B | -316.1 | -128.5 | 1692.4 | — | — | 3 | BEARISH | -53.1 |
| TRLV Trulieve Cannabis Corp. | $1.8B | — | — | — | — | — | — | BEARISH | — |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 7.8 | 4.5 | 6.7 | 13.0 | -2.1 | 6 | BEARISH | 0.8 |
| HROW Harrow Health, Inc. | $1.1B | -29.3 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -24.5 |
| INDV Indivior Pharmaceuticals Inc | $4.3B | 12.2 | -152.4 | 528.3 | 35.6 | 13.5 | 4 | BEARISH | 38.2 |
| ANIP ANI Pharmaceuticals, Inc. | $1.7B | 14.7 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | BEARISH | -24.5 |
| HYPMY Hypera S.A. | $3.8B | 8.0 | 13.2 | 12.8 | 21.0 | 31.8 | 8 | BEARISH | -2.2 |
| SUPN Supernus Pharmaceuticals, Inc. | $2.4B | -21.3 | -10.5 | -12.6 | -26.6 | 24.9 | 3 | BEARISH | -22.5 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.2 | 6.5 | -1.9 | 20.2 | 10.7 | 6 | BEARISH | -2.4 |
| ELAN Elanco Animal Health Incorporated | $11B | -55.2 | -3.0 | 3.7 | 3.9 | 12.0 | 5 | BEARISH | 2.7 |
| ETON Eton Pharmaceuticals, Inc. | $1.4B | 110.0 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 177.1 |
| DMPHF Dermapharm Holding SE | $2.4B | 13.8 | 25.6 | 13.0 | 8.1 | 0.5 | 5 | BEARISH | 20.6 |
| CURLF Curaleaf Holdings, Inc. | $1.8B | -61.9 | -4.2 | 0.5 | 3.7 | 2.7 | 7 | BEARISH | -2.1 |
| CHSYF China Medical System Holdings Limited | $2.7B | 13.5 | 8.6 | 9.0 | 21.9 | 9.2 | 4 | BEARISH | -17.8 |
| ARSUF Fagron N.V. | $2.0B | 18.9 | 16.7 | 10.8 | 8.4 | 11.8 | 4 | BEARISH | 9.8 |
| LABFF Laboratorios Farmaceuticos Rovi, S.A. | $3.4B | 17.0 | 29.3 | 19.6 | 39.1 | 3.3 | 6 | BEARISH | -25.9 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 11.7 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -16.3 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.5 | 5.7 | 8.4 | 19.4 | 24.4 | 6 | BEARISH | 20.0 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -4.9 | -4.9 | 0.0 | -14.3 | 5.6 | 6 | BEARISH | -40.3 |
| SFOSF Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | $5.8B | 18.0 | 10.7 | 6.3 | 8.4 | 53.9 | 7 | BEARISH | -34.2 |
| ULIHF The United Laboratories International Holdings Limited | $1.9B | 21.1 | 3.3 | 4.4 | 5.6 | -16.6 | 4 | BEARISH | -49.9 |
| BHC Bausch Health Companies Inc. | $2.4B | -2.1 | 86.8 | 12.2 | 9.0 | 10.5 | 5 | BULLISH | 1.8 |
| GNNDY GN Store Nord A/S | $2.4B | -29.7 | -5.4 | 1.6 | -1.0 | -25.4 | 4 | BULLISH | -5.1 |
| MD Pediatrix Medical Group, Inc. | $2.4B | 13.7 | 20.4 | 15.9 | 8.2 | 0.5 | 7 | BULLISH | 64.0 |
| ADMA ADMA Biologics, Inc. | $2.4B | 15.5 | 41.9 | 35.5 | 30.4 | 8.0 | 5 | BULLISH | -26.4 |
| VRDN Viridian Therapeutics, Inc. | $2.5B | -6.8 | -65.7 | 418.2 | -44760.2 | 23220.3 | 4 | BULLISH | 8.7 |
| SZUKF Suzuken Co., Ltd. | $2.4B | 10.6 | 9.3 | 8.6 | 0.5 | 5.0 | 4 | BULLISH | 18.9 |
| SLS SELLAS Life Sciences Group, Inc. | $2.3B | -57.6 | -39.6 | 55646.0 | — | — | 4 | BULLISH | 511.6 |
| ARHCF Alfresa Holdings Corporation | $2.5B | 11.2 | 5.7 | 7.8 | 0.2 | 3.6 | 5 | LEAN BULL | 17.9 |
| BEAM Beam Therapeutics Inc. | $2.5B | -30.4 | -8.1 | -184.5 | -25036.3 | 158.9 | 4 | LEAN BULL | -10.9 |
| UFPT UFP Technologies, Inc. | $2.3B | 31.5 | 17.1 | 13.3 | 12.0 | 7.3 | 7 | NEUTRAL | 46.7 |
| CLOV Clover Health Investments, Corp. | $2.4B | -114.3 | -5.1 | -8.3 | 3.8 | 54.0 | 4 | LEAN BEAR | 21.2 |
| GRDN Guardian Pharmacy Services, Inc. | $2.5B | 37.7 | 31.7 | 33.2 | 6.2 | 10.3 | 7 | BEARISH | 38.8 |
| CLDX Celldex Therapeutics, Inc. | $2.3B | -6.9 | -43.9 | -13685.9 | -334104.5 | -98.1 | 1 | BEARISH | 12.8 |
| MBX MBX Biosciences, Inc. Common Stock | $2.3B | -22.1 | -33.2 | 1634.0 | — | — | 2 | BEARISH | 211.6 |
| RCUS Arcus Biosciences, Inc. | $2.3B | -4.6 | -89.2 | 309.6 | -222.0 | -55.3 | 0 | BEARISH | 4.8 |
| ORPEF Emeis | $2.3B | -4.5 | -19.0 | 3.2 | -5.4 | 40.2 | 5 | BEARISH | 0.0 |
| NAMS NewAmsterdam Pharma Company N.V. | $2.3B | -9.4 | -36.8 | 8216.2 | -1732.9 | -88.9 | 2 | BEARISH | -42.6 |
| BKD Brookdale Senior Living Inc. | $2.4B | -16.5 | -362.1 | 10.3 | 3.2 | -2.3 | 6 | BEARISH | 7.7 |
| ZLDPF Zealand Pharma A/S | $2.4B | 5.9 | 16.3 | 57.2 | 87.2 | -49.2 | 3 | BEARISH | -54.1 |
| INCPF InnoCare Pharma Limited | $2.4B | 19.1 | 12.6 | 45.8 | 23.1 | 108.5 | 4 | BEARISH | -50.9 |
| TMDX TransMedics Group, Inc. | $2.5B | 15.8 | 36.3 | 18.7 | 7.7 | 25.8 | 3 | BEARISH | -46.6 |
| BHC Bausch Health Companies Inc. | $2.4B | -2.1 | 86.8 | 12.2 | 9.0 | 10.5 | 5 | BULLISH | 1.8 |
| TKPHF Takeda Pharmaceutical Company Limited | $66B | 55.2 | 2.5 | 2.8 | 9.3 | 3.3 | 6 | BULLISH | 41.6 |
| LZAGY Lonza Group AG | $54B | -409.5 | 13.5 | 10.5 | 17.5 | -9.7 | 8 | BULLISH | 4.3 |
| RPRX Royalty Pharma plc | $28B | 27.1 | 12.4 | 10.6 | 2.7 | 10.0 | 6 | BULLISH | 76.2 |
| WST West Pharmaceutical Services, Inc. | $28B | 50.6 | 19.1 | 19.0 | 17.7 | 12.4 | 9 | BULLISH | 34.0 |
| LH Labcorp Holdings Inc. | $27B | 27.2 | 11.7 | 8.6 | 8.0 | 6.4 | 8 | BULLISH | 19.8 |
| MEDP Medpace Holdings, Inc. | $19B | 36.7 | 117.9 | 1953.7 | 19.2 | 20.4 | 9 | BULLISH | 11.3 |
| CRL Charles River Laboratories International, Inc. | $17B | -74.1 | -7.7 | 6.9 | -0.1 | -0.7 | 4 | BULLISH | 82.2 |
| ASND Ascendis Pharma A/S | $15B | 18.3 | 121.1 | 76.2 | 61.0 | 114.8 | 7 | BULLISH | 21.7 |
| HALO Halozyme Therapeutics, Inc. | $14B | 36.5 | 173.7 | 32.5 | 47.8 | 41.2 | 5 | BULLISH | 94.3 |
| QGEN Qiagen N.V. | $10B | 25.7 | 11.9 | 11.2 | 19.3 | 3.0 | 8 | BULLISH | 1.7 |
| CAI Caris Life Sciences, Inc. | $9.1B | 90.5 | 20.1 | 61.1 | -0.2 | 445.5 | 7 | BULLISH | 8.4 |
| HNGE Hinge Health, Inc. | $9.0B | 84.6 | 30.4 | -235.0 | 20.5 | 417.7 | 7 | BULLISH | 129.6 |
| RGEDF Chemical Works of Gedeon Richter Plc | $7.4B | 10.5 | 16.2 | 24.3 | 15.9 | 1.8 | 5 | BULLISH | 32.8 |
| ALKS Alkermes plc | $7.3B | 110.0 | 3.9 | 2.9 | 0.1 | 10.8 | 4 | BULLISH | 48.7 |
| AMRX Amneal Pharmaceuticals, Inc. | $6.5B | 43.1 | -395.8 | 16.0 | 7.2 | 9.3 | 8 | BULLISH | 103.2 |
| BLCO Bausch + Lomb Corporation | $6.2B | -36.8 | -2.7 | 2.8 | -1.0 | 8.8 | 5 | BULLISH | 13.5 |
| KNSA Kiniksa Pharmaceuticals International, plc | $6.0B | 62.4 | 14.0 | 51.6 | 10.4 | 58.9 | 7 | BULLISH | 129.1 |
| MANE Veradermics, Incorporated | $5.8B | — | — | — | — | — | — | BULLISH | — |
| TFX Teleflex Incorporated | $5.8B | -6.0 | -28.8 | 1.3 | 17.9 | -14.5 | 5 | BULLISH | 5.8 |
| LFST LifeStance Health Group, Inc. | $4.9B | 100.6 | 3.4 | 4.1 | 5.4 | 20.4 | 7 | BULLISH | 151.9 |
| VCYT Veracyte, Inc. | $3.9B | 34.9 | 8.8 | 10.7 | 17.0 | 17.3 | 8 | BULLISH | 36.9 |
| ATRC AtriCure, Inc. | $3.0B | 289.9 | 2.2 | 2.9 | 5.8 | 13.9 | 8 | BULLISH | 63.9 |
| BVNRY Bavarian Nordic A/S | $2.9B | 13.0 | 12.3 | 7.1 | 36.0 | -5.8 | 7 | BULLISH | 1.9 |
| NRIX Nurix Therapeutics, Inc. | $2.8B | 10.6 | 44.0 | -1896.6 | 81.7 | 738.8 | 8 | BULLISH | 140.8 |
| GNNDY GN Store Nord A/S | $2.4B | -29.7 | -5.4 | 1.6 | -1.0 | -25.4 | 4 | BULLISH | -5.1 |
| FTRE Fortrea Holdings Inc. | $2.2B | -26.3 | -15.3 | 0.6 | -1.9 | -2.1 | 6 | BULLISH | 116.2 |
| AGIO Agios Pharmaceuticals, Inc. | $2.2B | -5.4 | -34.3 | -82.5 | -225.1 | 140.6 | 4 | BULLISH | -12.2 |
| LKFT Lakefront Biotherapeutics N.V. | $2.1B | — | — | — | — | — | — | BULLISH | — |
| SGRY Surgery Partners, Inc. | $2.1B | -33.9 | -5.2 | 5.9 | -1.8 | 4.0 | 5 | BULLISH | 2.4 |
| DHR Danaher Corporation | $162B | 37.9 | 8.3 | 6.3 | 18.8 | 5.5 | 7 | BULLISH | 4.8 |
| MDT Medtronic Plc | $122B | 23.0 | 10.7 | 7.8 | 15.1 | 9.8 | 9 | BULLISH | 3.6 |
| REGN Regeneron Pharmaceuticals, Inc. | $83B | 19.5 | 14.0 | 12.9 | 30.2 | 9.3 | 7 | BULLISH | 41.4 |
| CI Cigna Corporation | $81B | 12.3 | 15.5 | 11.8 | 2.3 | 7.7 | 8 | BULLISH | -0.6 |
| EW Edwards Lifesciences Corporation | $51B | 52.2 | 9.5 | 17.9 | 13.9 | 14.6 | 6 | BULLISH | 19.3 |
| SDZNY Sandoz Group AG | $42B | 64.7 | 7.2 | 10.1 | 1.9 | 29.1 | 6 | BULLISH | 59.1 |
| ILMN Illumina, Inc. | $41B | 51.7 | 32.4 | 18.2 | 17.9 | 4.9 | 7 | BULLISH | 179.2 |
| MTD Mettler-Toledo International Inc. | $33B | 37.8 | -736.4 | 46.7 | 22.7 | 6.9 | 8 | BULLISH | 17.5 |
| ORINY Orion Oyj | $30B | 23.3 | 53.6 | 46.3 | 26.9 | 22.6 | 7 | BULLISH | 44.0 |
| EXEL Exelixis, Inc. | $16B | 19.9 | 44.4 | 69.0 | 33.7 | 9.2 | 8 | BULLISH | 68.8 |
| PMCUF Pro Medicus Limited | $13B | 77.2 | 75.0 | 68.1 | 68.7 | 22.8 | 7 | BULLISH | -33.0 |
| AVTR Avantor, Inc. | $12B | -20.4 | -9.7 | -2.5 | 2.3 | -1.6 | 6 | BULLISH | 11.1 |
| GKOS Glaukos Corporation | $11B | -55.7 | -26.0 | -12.7 | -9.9 | 41.5 | 3 | BULLISH | 142.7 |
| HQY HealthEquity, Inc. | $8.6B | 36.0 | 11.4 | 9.9 | 18.7 | 7.3 | 8 | BULLISH | 4.5 |
| PACS PACS Group, Inc. | $7.5B | 28.1 | 28.1 | 6.9 | 5.3 | 15.2 | 8 | BULLISH | 277.8 |
| SSMXY Sysmex Corporation | $7.4B | 30.4 | 8.5 | 10.0 | 6.7 | 6.2 | 5 | BULLISH | 4.5 |
| DOCS Doximity, Inc. | $6.0B | 37.3 | 17.2 | 60.2 | 15.5 | 11.2 | 6 | BULLISH | -50.3 |
| MMSI Merit Medical Systems, Inc. | $5.6B | 38.2 | 9.2 | 7.3 | 9.3 | 10.2 | 9 | BULLISH | 13.0 |
| WAY Waystar Holding Corp. | $5.5B | 38.9 | 3.8 | 3.8 | 12.8 | 19.2 | 7 | BULLISH | -28.1 |
| CON Concentra Group Holdings Parent, Inc. | $5.0B | 25.8 | 48.5 | 66.4 | 10.8 | 14.0 | 9 | BULLISH | 92.0 |
| ARQT Arcutis Biotherapeutics, Inc. | $3.9B | 143.5 | 15.9 | 34.7 | 11.6 | 76.1 | 7 | BULLISH | 57.5 |
| MD Pediatrix Medical Group, Inc. | $2.4B | 13.7 | 20.4 | 15.9 | 8.2 | 0.5 | 7 | BULLISH | 64.0 |
| PRGO Perrigo Company plc | $2.2B | -1.3 | -49.6 | 3.1 | 7.3 | -4.2 | 4 | BULLISH | -23.7 |
| VCEL Vericel Corporation | $2.2B | 90.1 | 7.2 | 5.9 | 2.8 | 23.0 | 7 | BULLISH | 19.1 |
| BOEUF Bonesupport Holding AB (publ) | $2.1B | 77.4 | 29.2 | 54.1 | 22.6 | 23.4 | 8 | BULLISH | 28.9 |
| MRVI Maravai LifeSciences Holdings, Inc. | $2.1B | -15.4 | -32.9 | 24.4 | -24.1 | -3.3 | 5 | BULLISH | 142.2 |
| GEHC GE HealthCare Technologies Inc. | $32B | 20.4 | 15.4 | 10.6 | 10.8 | 1.4 | 5 | BULLISH | -9.0 |
| VRDN Viridian Therapeutics, Inc. | $2.5B | -6.8 | -65.7 | 418.2 | -44760.2 | 23220.3 | 4 | BULLISH | 8.7 |
| ADMA ADMA Biologics, Inc. | $2.4B | 15.5 | 41.9 | 35.5 | 30.4 | 8.0 | 5 | BULLISH | -26.4 |
| ABT Abbott Laboratories | $179B | 38.2 | 10.7 | 7.3 | 7.4 | 8.1 | 5 | BULLISH | -18.7 |
| SNY Sanofi | $100B | 23.1 | 5.7 | 6.4 | 2.8 | 13.4 | 6 | BULLISH | -18.9 |
| UTHR United Therapeutics Corporation | $25B | 19.6 | 19.3 | 31.3 | 42.5 | 2.5 | 6 | BULLISH | 41.2 |
| GH Guardant Health, Inc. | $23B | -51.0 | 171.6 | -88.3 | -35.9 | 42.7 | 6 | BULLISH | 146.8 |
| RDY Dr. Reddy's Laboratories Limited | $11B | 39.7 | 7.5 | 6.0 | 10.7 | -3.1 | 4 | BULLISH | -5.7 |
| PODD Insulet Corp. | $10B | 28.0 | 26.0 | 21.3 | 11.8 | 29.4 | 9 | BULLISH | -53.3 |
| BIO Bio-Rad Laboratories, Inc. | $9.9B | 45.7 | 3.1 | 2.2 | 57.1 | 1.4 | 7 | BULLISH | 12.1 |
| KYMR Kymera Therapeutics, Inc. | $9.1B | -36.2 | -24.2 | -30.7 | -94.2 | 134.8 | 6 | BULLISH | 100.8 |
| BLLN BillionToOne, Inc. | $5.1B | 165.3 | 6.0 | 25.2 | 7.4 | — | 4 | BULLISH | — |
| IRTC iRhythm Technologies, Inc. | $4.0B | -287.8 | -9.6 | -3.4 | -0.2 | 25.6 | 6 | BULLISH | -31.5 |
| LEGN Legend Biotech Corporation | $3.6B | -43.1 | -8.1 | -8.2 | 8.6 | 59.5 | 4 | BULLISH | -32.3 |
| PFE Pfizer Inc. | $171B | 39.4 | 5.0 | 11.3 | -1.6 | -0.2 | 7 | BULLISH | 22.5 |
| MCK McKesson Corporation | $117B | 25.8 | -148.0 | 237.7 | 0.6 | 8.8 | 8 | BULLISH | 20.7 |
| WILYY Demant A/S | $12B | 47.0 | 15.9 | 10.9 | 9.1 | 10.6 | 5 | BULLISH | 47.3 |
| HAE Haemonetics Corporation | $5.4B | 58.2 | 11.2 | 10.1 | 9.7 | 0.4 | 8 | BULLISH | 134.1 |
| HKMPY Hikma Pharmaceuticals PLC | $4.6B | 12.6 | 15.3 | 12.1 | 12.9 | 6.1 | 7 | BULLISH | -5.2 |
| PGNY Progyny, Inc. | $2.2B | 28.6 | 16.2 | 30.2 | 8.0 | 5.5 | 7 | BULLISH | 42.2 |
| NTRA Natera, Inc. | $58B | -302.1 | -12.5 | -23.6 | -8.9 | 37.8 | 6 | BULLISH | 113.4 |
| IDXX IDEXX Laboratories, Inc. | $44B | 39.4 | 74.2 | 46.5 | 27.8 | 12.8 | 9 | BULLISH | -12.4 |
| ZTS Zoetis Inc. | $33B | 12.9 | 64.4 | 26.3 | 28.0 | 1.4 | 6 | BULLISH | -46.2 |
| CLPBY Coloplast A/S | $17B | 38.7 | 18.5 | 70.9 | 19.9 | -2.9 | 5 | BULLISH | -23.4 |
| SNN Smith & Nephew plc | $13B | 19.6 | 11.8 | 9.9 | 9.8 | 5.3 | 7 | BULLISH | -15.5 |
| PEN Penumbra, Inc. | $13B | 79.2 | 11.4 | 13.6 | 8.9 | 17.6 | 6 | BULLISH | 28.1 |
| COO The Cooper Companies, Inc. | $12B | 20.4 | 6.8 | 6.3 | 40.6 | 4.7 | 6 | BULLISH | -18.5 |
| GILD Gilead Sciences, Inc. | $193B | -61.2 | -20.6 | -3.4 | -134.5 | 5.5 | 5 | BULLISH | 32.4 |
| ISRG Intuitive Surgical, Inc. | $160B | 53.3 | 18.0 | 22.6 | 17.1 | 20.5 | 7 | BULLISH | -18.4 |
| CVS CVS Health Corp. | $120B | 23.8 | 6.2 | 4.9 | 2.8 | 7.4 | 8 | BULLISH | 11.2 |
| SYK Stryker Corporation | $118B | 31.0 | 16.5 | 11.6 | 19.4 | 8.5 | 9 | BULLISH | -21.0 |
| SOAGY Sartorius AG ADR | $92B | 92.4 | 7.7 | 6.6 | 7.1 | 4.3 | 7 | BULLISH | 16.0 |
| WAT Waters Corporation | $45B | 116.6 | 1.9 | 1.5 | -8.3 | 52.5 | 5 | BULLISH | 30.3 |
| BIIB Biogen Inc. | $37B | 44.5 | 4.6 | 4.8 | 3.6 | -0.5 | 3 | BULLISH | 68.6 |
| GNMSF Genmab A/S | $28B | 35.0 | 3.9 | 11.9 | 26.2 | -82.1 | 4 | BULLISH | 47.7 |
| VTRS Viatris Inc. | $21B | -52.0 | -2.8 | -0.3 | -3.2 | 4.4 | 7 | BULLISH | 83.0 |
| ALGN Align Technology, Inc. | $11B | 26.4 | 10.2 | 12.3 | 10.3 | 4.4 | 7 | BULLISH | 12.4 |
| SYRE Spyre Therapeutics, Inc. | $8.3B | -50.8 | -23.0 | 359.8 | — | — | 3 | BULLISH | 323.8 |
| TGTX TG Therapeutics, Inc. | $8.3B | 18.5 | 100.3 | 73.5 | 3.2 | 76.1 | 6 | BULLISH | 69.3 |
| GNGBY Getinge AB (publ) | $7.3B | 26.0 | 9.1 | 8.1 | 8.5 | -3.9 | 7 | BULLISH | 13.6 |
| ORKA Oruka Therapeutics, Inc. | $5.3B | -38.8 | -18.2 | -50.3 | — | — | 4 | BULLISH | 251.6 |
| HTFL Heartflow, Inc. Common Stock | $4.9B | -40.7 | -42.3 | -39.8 | -24.6 | — | 2 | BULLISH | 52.7 |
| PLSE Pulse Biosciences, Inc. | $3.8B | -45.5 | -78.5 | -1410.2 | -5681.3 | — | 3 | BULLISH | 194.2 |
| IRON Disc Medicine, Inc. | $2.9B | -12.1 | -39.1 | 1672.3 | — | — | 1 | BULLISH | -6.7 |
| BHVN Biohaven Ltd. | $2.1B | -3.3 | -799.5 | -1083.0 | — | — | 3 | BULLISH | -7.9 |
| ZYME Zymeworks Inc. | $2.0B | -14.3 | -72.3 | -156.9 | -980.8 | -69.8 | 2 | BULLISH | 62.6 |
| ONTTF Oxford Nanopore Technologies plc | $2.7B | -18.6 | -25.6 | -36.2 | -41.1 | 14.4 | 4 | BULLISH | 41.7 |
| CHGCF Chugai Pharmaceutical Co., Ltd. | $74B | 30.2 | 23.7 | 45.1 | 34.1 | 12.6 | 6 | BULLISH | -0.7 |
| NBIX Neurocrine Biosciences, Inc. | $15B | 20.7 | 22.1 | 16.0 | 15.1 | 34.4 | 6 | BULLISH | 1.4 |
| ERAS Erasca, Inc. | $5.0B | -16.0 | -78.2 | -87.5 | — | — | 2 | BULLISH | 539.5 |
| CSLLY CSL Limited | $134B | -26.2 | -15.2 | 13.1 | -40.2 | 1.7 | 4 | BULLISH | 1.4 |
| CAH Cardinal Health, Inc. | $58B | 33.9 | -60.5 | 92.8 | 0.6 | 14.2 | 8 | BULLISH | 53.7 |
| BDX Becton, Dickinson and Company | $54B | 58.7 | 3.8 | 4.1 | 7.6 | -2.6 | 6 | BULLISH | 5.5 |
| A Agilent Technologies, Inc. | $49B | 34.9 | 21.0 | 14.9 | 19.3 | 8.6 | 7 | BULLISH | 19.9 |
| IQV IQVIA Holdings Inc. | $46B | 32.6 | 21.7 | 33.3 | 7.9 | 8.8 | 9 | BULLISH | 23.1 |
| OTSKY Otsuka Holdings Co., Ltd. | $42B | 15.8 | 13.8 | 12.2 | 16.7 | 10.9 | 8 | BULLISH | 44.2 |
| TRUMY Terumo Corporation | $22B | 21.2 | 11.0 | 9.6 | 22.6 | 15.6 | 5 | BULLISH | -8.6 |
| SONVF Sonova Holding AG | $20B | 38.9 | 20.4 | 17.2 | 19.7 | -7.1 | 6 | BULLISH | 22.9 |
| ZBH Zimmer Biomet Holdings, Inc. | $19B | 23.3 | 6.4 | 5.9 | 9.1 | 8.6 | 6 | BULLISH | -6.8 |
| ICLR ICON Public Limited Company | $14B | 42.6 | 3.5 | 5.5 | 3.5 | 2.0 | 6 | BULLISH | 2.7 |
| ESAIY Eisai Co., Ltd. | $9.2B | 33.8 | 3.8 | 3.3 | 7.8 | 248.0 | 6 | BULLISH | 9.7 |
| LGND Ligand Pharmaceuticals Incorporated | $6.0B | 31.1 | 22.0 | 11.3 | 76.2 | 54.9 | 5 | BULLISH | 66.7 |
| DSRLF DiaSorin S.p.A. | $4.4B | 25.4 | 14.2 | 8.9 | 14.0 | 46.3 | 5 | BULLISH | -2.4 |
| MAHLY MediPal Holdings Corporation | $4.1B | 14.8 | 7.5 | 8.7 | 1.4 | 5.9 | 7 | BULLISH | 23.9 |
| CDNA CareDx, Inc | $3.6B | 32.8 | 29.5 | -2.5 | 83.8 | 34.4 | 8 | BULLISH | 371.1 |
| CZMWY Carl Zeiss Meditec AG | $3.5B | 21.1 | 5.6 | 4.8 | 9.8 | 22.1 | 7 | BULLISH | -26.2 |
| SZUKF Suzuken Co., Ltd. | $2.4B | 10.6 | 9.3 | 8.6 | 0.5 | 5.0 | 4 | BULLISH | 18.9 |
| ADUS Addus HomeCare Corporation | $2.3B | 21.3 | 9.7 | 9.6 | 7.3 | 15.9 | 6 | BULLISH | -0.3 |
| AUPH Aurinia Pharmaceuticals Inc. | $2.2B | 7.3 | 66.1 | 127.2 | 45.0 | 19.8 | 7 | BULLISH | 45.1 |
| FSNUY Fresenius SE & Co. KGaA | $117B | 16.8 | 8.1 | 5.6 | 6.4 | 5.9 | 7 | BULLISH | -20.4 |
| GSK GSK plc | $102B | 15.3 | 25.5 | 18.8 | 5.2 | 5.0 | 7 | BULLISH | 18.9 |
| SEMHF Siemens Healthineers AG | $53B | 21.2 | 12.1 | 8.4 | 11.6 | 10.0 | 9 | BULLISH | -17.9 |
| DGX Quest Diagnostics Incorporated | $27B | 23.8 | 15.2 | 10.2 | 10.1 | 9.1 | 8 | BULLISH | 33.1 |
| SAUHY Straumann Holding AG | $19B | 41.2 | 17.3 | 21.7 | 18.1 | 3.0 | 6 | BULLISH | 4.9 |
| LQDA Liquidia Corporation | $3.8B | 29.0 | 131.8 | 391.9 | 43.5 | 2233.6 | 6 | BULLISH | 103.0 |
| SNPHY Santen Pharmaceutical Co., Ltd. | $3.6B | 14.7 | 13.6 | 14.9 | 10.4 | 0.9 | 8 | BULLISH | 14.7 |
| SLS SELLAS Life Sciences Group, Inc. | $2.3B | -57.6 | -39.6 | 55646.0 | — | — | 4 | BULLISH | 511.6 |
| CNC Centene Corp. | $35B | 23.2 | 6.8 | 6.4 | -0.1 | 4.8 | 7 | BULLISH | 101.6 |
| RVTY Revvity, Inc. | $18B | 77.1 | 3.2 | 3.5 | 7.1 | 5.5 | 6 | BULLISH | 63.7 |
| BAX Baxter International Inc. | $13B | -12.2 | -15.7 | -1.6 | 4.3 | 5.4 | 3 | BULLISH | 8.4 |
| TECH Bio-Techne Corporation | $11B | 62.1 | 9.0 | 8.9 | 17.0 | -0.4 | 7 | BULLISH | 10.3 |
| HLUBF H. Lundbeck A/S | $7.3B | 13.5 | 15.2 | 12.6 | 17.6 | 10.1 | 7 | BULLISH | 22.5 |
| IOVA Iovance Biotherapeutics, Inc. | $6.4B | -20.0 | -40.4 | -49.1 | -47.6 | 34.5 | 6 | BULLISH | 548.0 |
| CNVVY ConvaTec Group Plc | $6.3B | 50.8 | 7.6 | 10.2 | 4.4 | 5.5 | 5 | BULLISH | -2.0 |
| KOD Kodiak Sciences Inc. | $5.5B | -21.8 | -368.4 | -630.1 | — | — | 1 | BULLISH | 388.6 |
| PCRX Pacira BioSciences, Inc. | $1.4B | 103.4 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | BULLISH | 67.4 |
| KHTRF Knight Therapeutics Inc. | $810M | 76.7 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 98.5 |
| MRNA Moderna, Inc. | $80B | -26.1 | -39.0 | -90.1 | -539.3 | -27.2 | 2 | BULLISH | 724.0 |
| HOCPY HOYA Corporation | $56B | 33.4 | 27.3 | 46.1 | 25.7 | 14.2 | 6 | BULLISH | 12.2 |
| HLN Haleon plc | $45B | 20.5 | 10.1 | 8.4 | 13.6 | 1.3 | 8 | BULLISH | 8.9 |
| ALC Alcon Inc. | $34B | 53.4 | 2.9 | 3.6 | 0.0 | 7.8 | 6 | BULLISH | -8.8 |
| PHG Koninklijke Philips N.V. | $26B | 20.3 | 10.2 | 7.6 | 8.8 | -1.1 | 6 | BULLISH | -8.4 |
| STE STERIS plc | $23B | 27.9 | 11.4 | 9.7 | 13.4 | 8.4 | 8 | BULLISH | -4.9 |
| ATR AptarGroup, Inc. | $8.1B | 22.6 | 13.6 | 10.1 | 8.5 | 8.9 | 6 | BULLISH | -1.8 |
| AKBLF ALK-Abelló A/S | $7.4B | 40.0 | 21.2 | 23.9 | 18.9 | 16.4 | 8 | BULLISH | 12.8 |
| LVZPF Livzon Pharmaceutical Group Inc. | $6.1B | 15.9 | 11.5 | 16.4 | 15.3 | -14.4 | 4 | BULLISH | 0.0 |
| GRAL GRAIL Inc. | $5.9B | -15.4 | -16.1 | -24.9 | -246.7 | 23.1 | 5 | BULLISH | 68.5 |
| OPCH Option Care Health, Inc. | $4.7B | 23.5 | 16.0 | 10.6 | 3.7 | 5.9 | 5 | BULLISH | 12.1 |
| AMBBY Ambu A/S | $3.2B | 41.8 | 8.5 | 9.0 | 9.5 | -411.9 | 6 | BULLISH | -28.5 |
| PRVA Privia Health Group, Inc. | $2.9B | 97.1 | 0.0 | 0.0 | 1.4 | 24.1 | 1 | BULLISH | -16.0 |
| DRWKF Drägerwerk AG & Co. KGaA | $2.3B | 11.2 | 11.0 | 9.8 | 3.5 | 6.5 | 9 | BULLISH | 36.8 |
| ESLOF EssilorLuxottica S.A. | $94B | 33.6 | 6.5 | 5.2 | 10.6 | 7.4 | 6 | BULLISH | -44.5 |
| BSX Boston Scientific Corporation | $66B | 18.2 | 15.5 | 11.6 | 16.7 | 13.5 | 8 | BULLISH | -55.4 |
| ROIV Roivant Sciences Ltd. | $26B | -96.2 | -6.2 | -217.5 | -13164.4 | -67.6 | 1 | BULLISH | 100.5 |
| BMXXY bioMérieux S.A. | $12B | 23.2 | 11.2 | 8.9 | 11.5 | -3.5 | 7 | BULLISH | -28.0 |
| GMED Globus Medical, Inc. | $11B | 20.4 | 11.8 | 12.3 | 19.2 | 19.7 | 8 | BULLISH | 29.8 |
| OPHLY Ono Pharmaceutical Co., Ltd. | $7.4B | 15.2 | 9.5 | 11.3 | 20.8 | 3.3 | 9 | BULLISH | 29.5 |
| LIVN LivaNova PLC | $4.4B | 23.3 | 15.4 | 30.2 | 27.8 | 12.4 | 8 | BULLISH | 46.4 |
| CRON Cronos Group Inc. | $1.2B | 18.1 | 6.5 | 5.4 | 60.5 | 72.9 | 7 | BULLISH | 34.1 |
| ELV Elevance Health Inc. | $95B | 18.0 | 11.6 | 16.2 | 2.7 | 3.6 | 7 | BULLISH | 23.7 |
| TEVA Teva Pharmaceutical Industries Limited | $46B | 64.1 | 9.7 | 9.3 | -13.9 | 4.1 | 7 | BULLISH | 113.2 |
| MTHRY M3, Inc. | $8.2B | 27.1 | 12.1 | 16.9 | 10.1 | 17.7 | 7 | BULLISH | -17.1 |
| EKTAY Elekta AB (publ) | $2.2B | -61.6 | -4.4 | -49.1 | 7.5 | -7.8 | 4 | BULLISH | 9.3 |
| BBIO BridgeBio Pharma, Inc. | $13B | -19.4 | 32.4 | 57.9 | -62.5 | 202.4 | 4 | BULLISH | 27.9 |
| BRKR Bruker Corporation | $8.8B | -86.9 | -3.4 | 3.0 | -6.2 | 1.6 | 6 | BULLISH | 55.9 |
| SKHHY Sonic Healthcare Limited | $6.5B | 15.3 | 7.3 | 6.2 | 6.2 | 52.7 | 5 | BULLISH | -5.9 |
| RDNT RadNet, Inc. | $5.5B | -275.9 | -2.1 | 1.8 | 1.2 | 18.9 | 5 | BULLISH | -11.8 |
| ONC BeOne Medicines AG | $40B | 25.5 | 14.7 | 57.2 | 13.9 | 34.3 | 8 | BULLISH | 17.9 |
| PAHC Phibro Animal Health Corporation | $1.6B | 15.6 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | BULLISH | -9.1 |
| FSPKF Fisher & Paykel Healthcare Corporation Limited | $16B | 59.5 | 23.3 | 27.3 | 20.6 | 5.0 | 6 | BULLISH | 34.9 |
| COGT Cogent Biosciences, Inc. | $5.4B | -13.9 | -109.7 | 1964.0 | — | — | 3 | BULLISH | 111.6 |
| RCDTF Recordati Industria Chimica e Farmaceutica S.p.A. | $12B | 21.8 | 24.9 | 15.4 | 16.7 | 9.2 | 7 | BULLISH | -9.2 |
| ALMR Alamar Biosciences, Inc. | $2.1B | — | — | — | — | — | — | BULLISH | — |
| VRTX Vertex Pharmaceuticals Incorporated | $133B | 30.1 | 23.5 | 28.3 | 33.0 | 10.6 | 6 | BULLISH | 23.6 |
| SGIOY Shionogi & Co., Ltd. | $16B | 9.7 | 13.6 | 9.9 | 50.6 | 10.3 | 5 | BULLISH | 20.6 |
| SHTDF Sinopharm Group Co. Ltd. | $6.3B | 6.0 | 8.4 | 8.1 | 1.2 | -2.2 | 5 | BULLISH | -15.2 |
| SHPMY Shanghai Pharmaceuticals Holding Co., Ltd | $5.1B | 12.8 | 6.2 | 6.5 | 2.9 | 4.1 | 5 | BULLISH | -13.8 |
| RLAY Relay Therapeutics, Inc. | $4.0B | -12.0 | -36.8 | -2519.7 | -23916.3 | 23.9 | 4 | BULLISH | 174.6 |
| APNHY Aspen Pharmacare Holdings Limited | $4.2B | 26.8 | 3.2 | 5.3 | 6.6 | -20.1 | 7 | BULLISH | 69.4 |
| DYN Dyne Therapeutics, Inc. | $2.9B | -5.1 | -81.6 | 240.4 | — | — | 2 | BULLISH | -1.1 |
| ERFSF Eurofins Scientific SE | $17B | 28.6 | 12.8 | 4.6 | 8.2 | 3.3 | 6 | BULLISH | 25.6 |
| ITGR Integer Holdings Corporation | $4.3B | 34.3 | 7.5 | 5.4 | 5.1 | 2.6 | 7 | BULLISH | 73.8 |
| HUM Humana Inc. | $51B | 39.0 | 6.8 | 17.2 | 1.7 | 18.3 | 4 | BULLISH | 42.7 |
| ACHC Acadia Healthcare Company, Inc. | $2.9B | -2.4 | -44.5 | 6.1 | 1.3 | 4.3 | 4 | BULLISH | 27.8 |
| UCBJY UCB S.A. | $58B | 23.5 | 20.7 | 16.4 | 26.0 | 25.3 | 6 | LEAN BULL | 5.8 |
| BIOVF Swedish Orphan Biovitrum AB | $16B | 118.6 | 3.4 | 17.2 | 14.0 | 13.3 | 4 | LEAN BULL | 37.3 |
| PTGX Protagonist Therapeutics, Inc. | $9.0B | 115.9 | 11.0 | 84.1 | 76.3 | 34.8 | 7 | LEAN BULL | 88.5 |
| SHC Sotera Health Company | $5.2B | 32.3 | 27.8 | 10.6 | 16.7 | 8.1 | 7 | LEAN BULL | 9.7 |
| DFTX Definium Therapeutics, Inc. | $4.8B | -10.8 | -25.7 | 82.4 | — | — | 2 | LEAN BULL | — |
| CHEOY Cochlear Limited | $6.7B | 62.2 | 7.8 | 11.6 | -1.2 | -1.2 | 6 | LEAN BULL | -48.2 |
| NVST Envista Holdings Corp | $3.8B | 40.0 | 3.1 | 3.2 | 7.4 | 11.9 | 7 | LEAN BULL | 15.9 |
| SDGCF Sundrug Co.,Ltd. | $3.3B | 13.2 | 11.4 | 10.6 | 3.7 | 4.9 | 6 | LEAN BULL | 0.0 |
| ARHCF Alfresa Holdings Corporation | $2.5B | 11.2 | 5.7 | 7.8 | 0.2 | 3.6 | 5 | LEAN BULL | 17.9 |
| TSMRF Tsumura & Co. | $1.7B | 9.1 | 9.9 | 6.6 | 13.0 | 10.7 | 4 | LEAN BULL | 0.0 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 22.7 | 4.3 | 4.6 | 4.7 | 11.4 | 4 | LEAN BULL | 0.0 |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 20.8 | 4.7 | 3.2 | 7.7 | 7.1 | 7 | LEAN BULL | 54.4 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 13.9 | 6.9 | 7.9 | 28.0 | -6.6 | 4 | LEAN BULL | 8.3 |
| INSP Inspire Medical Systems, Inc. | $2.1B | 15.3 | 18.0 | 19.7 | 0.2 | 4.3 | 8 | LEAN BULL | -7.9 |
| IPSEY Ipsen S.A. | $58B | 24.7 | 11.5 | 16.3 | 18.2 | 8.0 | 6 | LEAN BULL | 22.7 |
| ELVN Enliven Therapeutics, Inc. | $3.0B | -26.6 | -15.3 | -6535.0 | — | — | 3 | LEAN BULL | 112.0 |
| NEOG Neogen Corporation | $2.7B | -49.2 | -2.7 | -0.2 | -5.3 | -0.3 | 7 | LEAN BULL | 101.5 |
| PHVS Pharvaris N.V. | $2.2B | -10.6 | -70.7 | 860.9 | — | — | 4 | LEAN BULL | 39.0 |
| BMY Bristol-Myers Squibb Company | $126B | 13.6 | 46.7 | 17.8 | 25.6 | 3.1 | 8 | LEAN BULL | 46.8 |
| MKGAF Merck KGaA | $70B | 26.8 | 8.1 | 8.1 | 9.0 | -0.4 | 7 | LEAN BULL | 19.4 |
| ALPMF Astellas Pharma Inc. | $30B | 12.3 | 21.4 | 16.9 | 22.1 | 17.3 | 7 | LEAN BULL | 60.4 |
| JDHIY JD Health International Inc. | $16B | 16.1 | 10.3 | 31.0 | 8.4 | 19.6 | 6 | LEAN BULL | -43.9 |
| ALBHF Alibaba Health Information Technology Limited | $6.3B | 19.9 | 11.2 | 20.8 | 3.8 | -36.2 | 3 | LEAN BULL | -50.2 |
| TEM Tempus AI, Inc. | $12B | -50.5 | -67.4 | -19.8 | 1.5 | 50.4 | 4 | LEAN BULL | -19.1 |
| BEAM Beam Therapeutics Inc. | $2.5B | -30.4 | -8.1 | -184.5 | -25036.3 | 158.9 | 4 | LEAN BULL | -10.9 |
| NEO NeoGenomics, Inc. | $2.2B | -43.5 | -6.3 | -4.8 | 1.1 | 11.2 | 5 | LEAN BULL | 61.9 |
| FMS Fresenius Medical Care AG & Co. KGaA | $12B | 12.2 | 7.3 | 6.7 | 4.5 | -0.5 | 7 | NEUTRAL | -17.4 |
| MSMKF MatsukiyoCocokara & Co. | $5.8B | 17.3 | 11.1 | 12.6 | 5.1 | 5.7 | 8 | NEUTRAL | -16.3 |
| ICUI ICU Medical, Inc. | $4.2B | 136.0 | 1.4 | 2.7 | 3.5 | -9.0 | 6 | NEUTRAL | 32.2 |
| CLCGY Clicks Group Limited | $3.1B | 15.5 | 47.7 | 39.1 | 6.5 | 6.3 | 6 | NEUTRAL | -37.3 |
| AVAH Aveanna Healthcare Holdings Inc. | $2.9B | 9.6 | 199.1 | 30.4 | 6.0 | 20.3 | 6 | NEUTRAL | 34.7 |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.6 | 12.5 | 20.6 | 12.8 | 4 | NEUTRAL | -1.1 |
| OSCR Oscar Health, Inc. | $8.0B | 18.3 | 34.3 | -9.6 | 7.4 | 42.8 | 7 | NEUTRAL | 62.6 |
| COR Cencora, Inc. | $63B | 24.1 | 104.3 | 26.5 | 0.9 | 5.1 | 7 | NEUTRAL | -2.0 |
| KYKOF Kyowa Kirin Co., Ltd. | $8.1B | 15.4 | 9.3 | 14.2 | 12.8 | 7.4 | 7 | NEUTRAL | -9.5 |
| HCA HCA Healthcare, Inc. | $102B | 54.6 | -124.7 | 23.3 | 8.4 | 7.3 | 6 | NEUTRAL | 0.8 |
| AAVXF Abivax S.A. | $12B | -17.0 | -221.8 | 440.6 | — | -133.5 | 4 | NEUTRAL | 57.0 |
| BCHMF Bachem Holding AG | $6.8B | 42.0 | 10.6 | 8.2 | 15.4 | 4.3 | 3 | NEUTRAL | 24.7 |
| BUHPF Bumrungrad Hospital Public Company Limited | $4.8B | 20.9 | 27.3 | 37.3 | 30.3 | 1.6 | 5 | NEUTRAL | 23.7 |
| ANSLY Ansell Limited | $4.7B | 22.2 | 10.6 | 9.5 | 10.8 | 7.1 | 8 | NEUTRAL | 43.8 |
| TCHBF Tecan Group AG | $3.5B | -26.8 | -9.7 | 2.8 | 2.9 | -4.2 | 6 | NEUTRAL | 45.2 |
| CHJTF CSPC Pharmaceutical Group Limited | $14B | 10.4 | 20.7 | 36.7 | 32.8 | 88.1 | 6 | NEUTRAL | 13.3 |
| TXG 10x Genomics, Inc. | $9.3B | -132.2 | -9.4 | -19.8 | -11.9 | -4.3 | 5 | NEUTRAL | 466.6 |
| ABCL AbCellera Biologics Inc. | $3.8B | -23.8 | -17.3 | -36.2 | -1368.6 | 101.3 | 4 | NEUTRAL | 126.7 |
| DVA DaVita Inc. | $12B | 15.6 | -149.4 | 17.9 | 7.5 | 6.4 | 8 | NEUTRAL | 40.7 |
| TSUSF Tsuruha Holdings Inc. | $4.2B | 16.8 | 6.2 | 12.0 | 2.8 | 16.1 | 5 | NEUTRAL | 0.0 |
| NONOF Novo Nordisk A/S | $172B | 9.9 | 59.8 | 35.2 | 26.7 | 5.6 | 5 | NEUTRAL | -28.1 |
| IHHHF IHH Healthcare Berhad | $15B | 30.8 | 7.3 | 6.1 | 8.1 | 7.1 | 5 | NEUTRAL | 43.7 |
| DNPUF Sumitomo Pharma Co., Ltd. | $6.4B | 6.9 | 39.1 | 10.3 | 13.1 | 14.5 | 6 | NEUTRAL | 5.6 |
| SGFEF Siegfried Holding AG | $3.9B | 18.4 | 17.0 | 9.4 | 10.8 | 3.4 | 4 | NEUTRAL | -15.8 |
| ADPT Adaptive Biotechnologies Corporation | $4.1B | -67.9 | -39.6 | -14.1 | -55.6 | 50.1 | 5 | NEUTRAL | 60.6 |
| OGN Organon & Co. | $3.6B | 17.4 | 24.0 | 6.0 | 6.9 | -2.5 | 5 | NEUTRAL | 50.4 |
| CHE Chemed Corporation | $6.7B | 24.2 | 27.1 | 23.2 | 10.1 | 3.3 | 6 | NEUTRAL | 16.6 |
| ZLAB Zai Lab Limited | $2.7B | -13.3 | -26.9 | -85.4 | -47.8 | 5.1 | 3 | NEUTRAL | -10.4 |
| UFPT UFP Technologies, Inc. | $2.3B | 31.5 | 17.1 | 13.3 | 12.0 | 7.3 | 7 | NEUTRAL | 46.7 |
| RYTM Rhythm Pharmaceuticals, Inc. | $6.2B | -29.6 | -200.0 | 144.2 | -69.2 | 53.5 | 4 | NEUTRAL | -16.6 |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 14.7 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | NEUTRAL | 4.3 |
| PBH Prestige Consumer Healthcare Inc. | $2.3B | 13.2 | 9.1 | 5.5 | 11.0 | -1.4 | 4 | LEAN BEAR | -23.8 |
| AHICF Asahi Intecc Co., Ltd. | $5.7B | 29.6 | 20.0 | 27.8 | 14.6 | 21.6 | 9 | LEAN BEAR | 32.6 |
| GEDSF Gedeon Richter PLC | $4.5B | 10.5 | 16.4 | 22.0 | 29.6 | 4.8 | 7 | LEAN BEAR | 0.0 |
| GLPGF Lakefront Biotherapeutics | $2.1B | 3.9 | 20.2 | 39.4 | 17.4 | 259.3 | 5 | LEAN BEAR | -4.5 |
| BAYRY Bayer AG | $48B | -26.0 | -5.5 | 6.4 | 2.0 | -1.5 | 4 | LEAN BEAR | 59.6 |
| BDULF Bangkok Dusit Medical Services Public Company Limited | $9.7B | 20.6 | 15.0 | 12.4 | 12.1 | 1.3 | 4 | LEAN BEAR | -3.2 |
| SUVPF Sartorius AG | $19B | 92.4 | 7.7 | 6.7 | 7.1 | 3.6 | 7 | LEAN BEAR | -0.5 |
| LNTH Lantheus Holdings, Inc. | $6.5B | 23.8 | 22.2 | 17.1 | 19.3 | 2.3 | 5 | LEAN BEAR | 78.7 |
| EWTX Edgewise Therapeutics, Inc. | $4.2B | -21.4 | -38.0 | 1912.5 | — | — | 1 | LEAN BEAR | 160.4 |
| ARGX argenx SE | $55B | 41.6 | 26.0 | 50.1 | 29.8 | 162.5 | 7 | LEAN BEAR | 8.0 |
| MOH Molina Healthcare, Inc. | $11B | -327.0 | -1.2 | -44.2 | 0.4 | -2.1 | 5 | LEAN BEAR | 22.1 |
| SRRK Scholar Rock Holding Corporation | $5.0B | -12.8 | -167.8 | 931.3 | — | — | 2 | LEAN BEAR | 43.2 |
| ACAD Acadia Pharmaceuticals Inc. | $3.4B | 9.0 | 35.7 | 63.9 | 10.2 | 11.8 | 5 | LEAN BEAR | -8.4 |
| CLOV Clover Health Investments, Corp. | $2.4B | -114.3 | -5.1 | -8.3 | 3.8 | 54.0 | 4 | LEAN BEAR | 21.2 |
| HNGZY Hangzhou Tigermed Consulting Co., Ltd | $6.9B | 603.3 | 0.5 | 1.6 | -24.2 | 12.0 | 6 | LEAN BEAR | 11.2 |
| SHJBF Shanghai Junshi Biosciences Co., Ltd. | $4.8B | -70.9 | -7.1 | -6.3 | 4.4 | 29.7 | 5 | LEAN BEAR | -20.8 |
| MCVEF Medicover AB (publ) | $4.1B | 44.2 | 16.9 | 6.8 | 3.8 | 9.4 | 7 | LEAN BEAR | 0.0 |
| MIRM Mirum Pharmaceuticals, Inc. | $5.2B | -5.9 | -703.0 | -27.3 | -38.1 | 44.0 | 3 | LEAN BEAR | 22.2 |
| CELC Celcuity Inc. | $3.2B | -15.9 | -1433.7 | 1325.2 | — | — | 3 | LEAN BEAR | -4.1 |
| INCY Incyte Corporation | $23B | 14.3 | 30.7 | 82.1 | 35.0 | 26.9 | 8 | LEAN BEAR | 27.7 |
| TWST Twist Bioscience Corporation | $9.2B | -72.0 | -29.6 | -29.2 | -29.6 | 19.2 | 2 | LEAN BEAR | 368.6 |
| PTKFF PT Kalbe Farma Tbk. | $2.0B | 9.2 | 15.4 | 17.6 | 9.1 | 13.2 | 5 | LEAN BEAR | -18.5 |
| DSNKY Daiichi Sankyo Company, Limited | $33B | 19.5 | 15.1 | 12.5 | 11.9 | 17.4 | 5 | LEAN BEAR | -37.5 |
| BTSG BrightSpring Health Services, Inc. Common Stock | $12B | 40.8 | 15.5 | 10.3 | 2.2 | 19.9 | 7 | LEAN BEAR | 74.0 |
| IMNM Immunome, Inc. | $2.1B | -7.4 | -64.0 | -2208.4 | — | -100.0 | 4 | LEAN BEAR | 19.6 |
| XENE Xenon Pharmaceuticals Inc. | $3.4B | -7.6 | -43.6 | -109.7 | — | -100.0 | 3 | BEARISH | -11.7 |
| STVN Stevanato Group S.p.A. | $5.3B | 36.8 | 9.1 | 7.2 | 7.6 | 6.7 | 6 | BEARISH | -24.8 |
| ALVOW Alvotech | $3.9B | -8.1 | 98.5 | 3.3 | -63.2 | -12.2 | 0 | BEARISH | -85.2 |
| AXGN AxoGen, Inc. | $2.2B | -55.5 | -18.2 | -5.6 | -2.2 | 23.6 | 4 | BEARISH | 106.2 |
| TNGX Tango Therapeutics, Inc. | $3.9B | -26.9 | -21.3 | -253.2 | — | 121.5 | 3 | BEARISH | 205.2 |
| HCM HUTCHMED (China) Limited | $2.6B | 145.4 | 46.6 | 11.0 | 5.7 | -11.8 | 6 | BEARISH | -6.5 |
| GRDN Guardian Pharmacy Services, Inc. | $2.5B | 37.7 | 31.7 | 33.2 | 6.2 | 10.3 | 7 | BEARISH | 38.8 |
| WXIBF WuXi Biologics (Cayman) Inc. | $26B | 32.5 | 10.6 | 16.0 | 20.7 | 16.0 | 9 | BEARISH | 20.2 |
| PANHF Ping An Healthcare and Technology Company Limited | $2.1B | 20.7 | 4.6 | 5.6 | 8.8 | 2.9 | 6 | BEARISH | -61.7 |
| EHC Encompass Health Corporation | $12B | 19.5 | 25.5 | 16.7 | 9.6 | 9.5 | 9 | BEARISH | -3.7 |
| BIOGY BioGaia AB (publ) | $1.3B | 31.7 | 31.8 | 52.6 | 27.5 | 13.1 | 5 | BEARISH | 19.9 |
| PRAX Praxis Precision Medicines, Inc. | $7.1B | -20.7 | -38.9 | -51.2 | — | -100.0 | 4 | BEARISH | 53.8 |
| RGC Regencell Bioscience Holdings Limited | $3.8B | -316.1 | -128.5 | 1692.4 | — | — | 3 | BEARISH | -53.1 |
| CLDX Celldex Therapeutics, Inc. | $2.3B | -6.9 | -43.9 | -13685.9 | -334104.5 | -98.1 | 1 | BEARISH | 12.8 |
| TRLV Trulieve Cannabis Corp. | $1.8B | — | — | — | — | — | — | BEARISH | — |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 7.8 | 4.5 | 6.7 | 13.0 | -2.1 | 6 | BEARISH | 0.8 |
| HROW Harrow Health, Inc. | $1.1B | -29.3 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -24.5 |
| RSMDF ResMed Inc. | $36B | 24.0 | 24.3 | 25.3 | 26.2 | 9.9 | 7 | BEARISH | -15.5 |
| HSIC Henry Schein, Inc. | $9.5B | 24.3 | 12.2 | 8.7 | 2.7 | 6.5 | 7 | BEARISH | 32.0 |
| CSMYF COSMOS Pharmaceutical Corporation | $3.2B | 14.9 | 11.7 | 9.8 | 2.9 | 9.5 | 6 | BEARISH | -13.4 |
| BTSGU BrightSpring Health Services, Inc. Tangible Equity Unit | $12B | 40.8 | 15.5 | 10.3 | 2.2 | 19.9 | 7 | BEARISH | 68.8 |
| UHS Universal Health Services, Inc. | $11B | 7.4 | 21.0 | 12.5 | 7.7 | 10.0 | 8 | BEARISH | -15.7 |
| NHNKY Nihon Kohden Corporation | $3.1B | 19.0 | 7.8 | 7.9 | -1.6 | 2.6 | 9 | BEARISH | -28.8 |
| PCVX Vaxcyte, Inc. | $9.5B | -7.9 | -36.5 | -66.4 | — | — | 0 | BEARISH | 43.7 |
| DNLI Denali Therapeutics Inc. | $2.9B | -6.8 | -54.9 | -281.7 | -3539.2 | — | 3 | BEARISH | 20.4 |
| RGEN Repligen Corporation | $11B | -837.1 | -0.6 | -1.4 | -18.4 | 13.8 | 4 | BEARISH | 5.7 |
| ARWR Arrowhead Pharmaceuticals, Inc. | $8.2B | -26.4 | -64.8 | 65.7 | -258.2 | 12.2 | 4 | BEARISH | 55.3 |
| IONS Ionis Pharmaceuticals, Inc. | $7.1B | -12.7 | -105.4 | -58.5 | -42.8 | -7.4 | 3 | BEARISH | -38.0 |
| PTCT PTC Therapeutics, Inc. | $5.1B | -126.7 | 20.6 | -5.4 | 23.2 | -42.8 | 2 | BEARISH | -6.5 |
| GALNF Galenica AG | $5.0B | 27.7 | 11.2 | 6.8 | 3.1 | 6.2 | 4 | BEARISH | 32.2 |
| INDV Indivior Pharmaceuticals Inc | $4.3B | 12.2 | -152.4 | 528.3 | 35.6 | 13.5 | 4 | BEARISH | 38.2 |
| AMLX Amylyx Pharmaceuticals, Inc. | $3.4B | -20.1 | -74.7 | 2020.5 | — | 100.0 | 5 | BEARISH | 99.7 |
| MBX MBX Biosciences, Inc. Common Stock | $2.3B | -22.1 | -33.2 | 1634.0 | — | — | 2 | BEARISH | 211.6 |
| VERA Vera Therapeutics, Inc. | $2.0B | -5.1 | -91.8 | 2030.6 | — | — | 1 | BEARISH | 2.6 |
| ANIP ANI Pharmaceuticals, Inc. | $1.7B | 14.7 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | BEARISH | -24.5 |
| SOLV Solventum Corporation | $15B | 10.1 | 34.0 | 18.1 | 4.2 | -0.9 | 7 | BEARISH | 16.2 |
| RADLY Raia Drogasil S.A. | $7.2B | 20.8 | 19.4 | 16.9 | 3.8 | 10.9 | 7 | BEARISH | -17.4 |
| THC Tenet Healthcare Corporation | $22B | 10.0 | 53.3 | 19.1 | 14.7 | 5.4 | 7 | BEARISH | 24.5 |
| DNTH Dianthus Therapeutics, Inc. | $4.3B | -611.7 | -4.1 | -60.1 | -6598.6 | -60.8 | 3 | BEARISH | 141.6 |
| OCPNF Olympus Corporation | $12B | 24.6 | 10.6 | 12.7 | 7.9 | 7.8 | 5 | BEARISH | -9.8 |
| GNNSF Genscript Biotech Corporation | $9.6B | -15.7 | -15.4 | 2.9 | -32.0 | 53.1 | 4 | BEARISH | 97.7 |
| HYPMY Hypera S.A. | $3.8B | 8.0 | 13.2 | 12.8 | 21.0 | 31.8 | 8 | BEARISH | -2.2 |
| MMED MiniMed Group, Inc. | $5.2B | — | — | — | — | — | — | BEARISH | — |
| CGON CG Oncology Inc. | $5.5B | -23.3 | -26.4 | -2066.1 | -6832.8 | 1030.3 | 3 | BEARISH | 44.1 |
| CRSP CRISPR Therapeutics AG | $4.8B | -10.8 | -26.1 | -253.2 | -895.3 | -62.7 | 3 | BEARISH | -23.9 |
| PBLS Parabilis Medicines, Inc. | $3.0B | — | — | — | — | — | — | BEARISH | — |
| SUPN Supernus Pharmaceuticals, Inc. | $2.4B | -21.3 | -10.5 | -12.6 | -26.6 | 24.9 | 3 | BEARISH | -22.5 |
| IVBXF Innovent Biologics, Inc. | $20B | 97.5 | 6.9 | 67.2 | 14.5 | 35.4 | 6 | BEARISH | -11.4 |
| CAMRF Camurus AB | $3.7B | 58.8 | 15.8 | 89.3 | 34.3 | -0.2 | 6 | BEARISH | -10.3 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.2 | 6.5 | -1.9 | 20.2 | 10.7 | 6 | BEARISH | -2.4 |
| IMVT Immunovant, Inc. | $5.9B | -10.2 | -80.1 | 707.5 | -2159.6 | — | 2 | BEARISH | 52.5 |
| HRMY Harmony Biosciences Holdings, Inc. | $2.1B | 12.1 | 20.5 | 35.7 | 28.9 | 24.3 | 5 | BEARISH | 25.4 |
| RCUS Arcus Biosciences, Inc. | $2.3B | -4.6 | -89.2 | 309.6 | -222.0 | -55.3 | 0 | BEARISH | 4.8 |
| ELAN Elanco Animal Health Incorporated | $11B | -55.2 | -3.0 | 3.7 | 3.9 | 12.0 | 5 | BEARISH | 2.7 |
| RVMDW Revolution Medicines, Inc. Warrant | $40B | -21.0 | -79.1 | 186.4 | — | — | 1 | BEARISH | 2251.5 |
| ALNY Alnylam Pharmaceuticals, Inc. | $30B | 37.2 | 100.7 | -152.8 | 12.7 | 95.1 | 6 | BEARISH | -51.1 |
| ENSG The Ensign Group, Inc. | $10B | 24.5 | 17.0 | 8.1 | 6.9 | 18.9 | 7 | BEARISH | -8.9 |
| KRYS Krystal Biotech, Inc. | $9.2B | 38.8 | 20.1 | 40.4 | 45.9 | 22.6 | 7 | BEARISH | 72.2 |
| BMRN BioMarin Pharmaceutical Inc. | $11B | 145.7 | 1.2 | 1.4 | 4.5 | 11.2 | 4 | BEARISH | 1.6 |
| IBRX ImmunityBio, Inc. | $8.7B | -8.9 | 122.7 | 33.7 | -449.6 | 192.9 | 4 | BEARISH | 249.4 |
| ETON Eton Pharmaceuticals, Inc. | $1.4B | 110.0 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 177.1 |
| WUXAY WuXi AppTec Co., Ltd. | $68B | 15.5 | 30.2 | 35.4 | 39.1 | 25.0 | 8 | BEARISH | 66.6 |
| DXCM DexCom, Inc. | $29B | 30.3 | 38.5 | 42.9 | 19.0 | 15.5 | 9 | BEARISH | 11.7 |
| HIMS Hims & Hers Health, Inc. | $6.2B | -45.8 | -32.0 | -7.1 | -11.5 | 28.0 | 4 | BEARISH | -42.7 |
| RTEZ Rest Ez Inc. | $4.2B | — | — | — | — | — | — | BEARISH | 0.0 |
| TARS Tarsus Pharmaceuticals, Inc. | $3.2B | -64.9 | -13.7 | 268.1 | -10.7 | 105.2 | 5 | BEARISH | 7.1 |
| DMPHF Dermapharm Holding SE | $2.4B | 13.8 | 25.6 | 13.0 | 8.1 | 0.5 | 5 | BEARISH | 20.6 |
| BLTE Belite Bio, Inc | $5.9B | -52.8 | -20.8 | -11.5 | — | — | 3 | BEARISH | 57.0 |
| YPHDF Ypsomed Holding AG | $5.7B | 24.2 | 31.1 | 17.4 | 22.5 | -2.3 | 8 | BEARISH | -8.1 |
| VRBCF Virbac S.A. | $3.2B | 18.8 | 13.6 | 12.7 | 11.4 | 3.9 | 5 | BEARISH | 10.8 |
| MEDGF Medacta Group S.A. | $2.7B | 33.6 | 17.1 | 9.8 | 11.4 | 8.9 | 4 | BEARISH | 63.9 |
| ORPEF Emeis | $2.3B | -4.5 | -19.0 | 3.2 | -5.4 | 40.2 | 5 | BEARISH | 0.0 |
| CURLF Curaleaf Holdings, Inc. | $1.8B | -61.9 | -4.2 | 0.5 | 3.7 | 2.7 | 7 | BEARISH | -2.1 |
| CYTK Cytokinetics, Incorporated | $8.5B | -8.5 | 329.8 | 811.2 | -622.8 | -17.2 | 2 | BEARISH | 6.4 |
| NAMS NewAmsterdam Pharma Company N.V. | $2.3B | -9.4 | -36.8 | 8216.2 | -1732.9 | -88.9 | 2 | BEARISH | -42.6 |
| RVMD Revolution Medicines, Inc. | $40B | -21.0 | -79.1 | 186.4 | — | — | 1 | BEARISH | 241.8 |
| BNTX BioNTech SE | $22B | -11.6 | -9.3 | -18.0 | -777.3 | -8.2 | 2 | BEARISH | -17.6 |
| NHC National HealthCare Corporation | $3.7B | 23.5 | 13.1 | 12.6 | 9.9 | 6.9 | 8 | BEARISH | 72.6 |
| IDYA IDEAYA Biosciences, Inc. | $3.4B | -17.4 | -16.2 | -42.9 | -1269.6 | 3244.7 | 4 | BEARISH | 14.8 |
| TLX Telix Pharmaceuticals Limited | $3.1B | 96.1 | 8.6 | -1.0 | 8.0 | 10.5 | 4 | BEARISH | -16.5 |
| PGEN Precigen, Inc. | $2.2B | -5.4 | -4640.4 | -30.1 | 36.5 | 1875.0 | 5 | BEARISH | 42.0 |
| JAZZ Jazz Pharmaceuticals plc | $14B | 13.6 | 22.1 | 26.4 | 16.0 | 12.6 | 8 | BEARISH | 49.3 |
| MDGL Madrigal Pharmaceuticals, Inc. | $10B | -34.2 | -53.3 | -778.9 | -15.9 | 149.0 | 2 | BEARISH | 4.5 |
| CORT Corcept Therapeutics Incorporated | $9.3B | 168.4 | 8.1 | 3.1 | 16.5 | 16.0 | 6 | BEARISH | 20.8 |
| RMYHY Ramsay Health Care Limited | $9.2B | 41.0 | 6.6 | 4.2 | 1.8 | 4.2 | 7 | BEARISH | 85.2 |
| TVTX Travere Therapeutics, Inc. | $4.7B | -113.1 | -151.8 | -21.0 | -20.5 | 77.1 | 6 | BEARISH | 81.3 |
| HAWPY Haw Par Corporation Limited | $3.0B | 12.4 | 5.2 | 1.6 | 93.0 | -12.8 | 4 | BEARISH | -20.4 |
| CHSYF China Medical System Holdings Limited | $2.7B | 13.5 | 8.6 | 9.0 | 21.9 | 9.2 | 4 | BEARISH | -17.8 |
| ARSUF Fagron N.V. | $2.0B | 18.9 | 16.7 | 10.8 | 8.4 | 11.8 | 4 | BEARISH | 9.8 |
| INSM Insmed Incorporated | $20B | -23.1 | -87.2 | -364.8 | -3.1 | 185.8 | 5 | BEARISH | -40.5 |
| GIKLY Grifols, S.A. | $15B | 15.9 | 8.4 | 7.4 | 8.2 | -0.2 | 6 | BEARISH | -19.0 |
| REGMF RemeGen Co., Ltd. | $5.6B | 9.3 | 108.3 | 139.6 | 83.4 | 283.6 | 7 | BEARISH | -7.7 |
| LABFF Laboratorios Farmaceuticos Rovi, S.A. | $3.4B | 17.0 | 29.3 | 19.6 | 39.1 | 3.3 | 6 | BEARISH | -25.9 |
| AMFPF Amplifon S.p.A. | $3.0B | 42.9 | 5.7 | 7.2 | 6.4 | -0.2 | 5 | BEARISH | -36.0 |
| BKD Brookdale Senior Living Inc. | $2.4B | -16.5 | -362.1 | 10.3 | 3.2 | -2.3 | 6 | BEARISH | 7.7 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 11.7 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -16.3 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.5 | 5.7 | 8.4 | 19.4 | 24.4 | 6 | BEARISH | 20.0 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -4.9 | -4.9 | 0.0 | -14.3 | 5.6 | 6 | BEARISH | -40.3 |
| MDLN Medline Inc. | $30B | 37.7 | 3.2 | 4.4 | 0.8 | — | 4 | BEARISH | — |
| SMMT Summit Therapeutics Inc. | $12B | -13.7 | -192.5 | 1714.4 | — | — | 3 | BEARISH | -20.5 |
| SBMFF Sino Biopharmaceutical Limited | $12B | 31.0 | 21.1 | 40.0 | 17.7 | 28.2 | 7 | BEARISH | -22.9 |
| AXSM Axsome Therapeutics, Inc. | $7.6B | -37.9 | -245.1 | 859.1 | -23.5 | 56.9 | 5 | BEARISH | 9.8 |
| SFOSF Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | $5.8B | 18.0 | 10.7 | 6.3 | 8.4 | 53.9 | 7 | BEARISH | -34.2 |
| TRSBF 3SBio Inc. | $4.3B | 3.5 | 37.1 | 80.3 | 25.3 | 93.8 | 7 | BEARISH | -51.7 |
| VKTX Viking Therapeutics, Inc. | $3.1B | -5.3 | -88.9 | 495.6 | — | — | 1 | BEARISH | -27.7 |
| BRCTF BioArctic AB | $2.6B | 265.7 | 5.2 | 77.4 | -4.5 | -46.1 | 3 | BEARISH | -8.6 |
| TMDX TransMedics Group, Inc. | $2.5B | 15.8 | 36.3 | 18.7 | 7.7 | 25.8 | 3 | BEARISH | -46.6 |
| ZLDPF Zealand Pharma A/S | $2.4B | 5.9 | 16.3 | 57.2 | 87.2 | -49.2 | 3 | BEARISH | -54.1 |
| INCPF InnoCare Pharma Limited | $2.4B | 19.1 | 12.6 | 45.8 | 23.1 | 108.5 | 4 | BEARISH | -50.9 |
| ULIHF The United Laboratories International Holdings Limited | $1.9B | 21.1 | 3.3 | 4.4 | 5.6 | -16.6 | 4 | BEARISH | -49.9 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
BHC vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F